Reduction of Hepatitis B Surface Antigen Levels And Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients Receiving 10 Years of Nucleoside Analogue Therapy
2013 · Hepatology · 104 citations
https://doi.org/10.1002/hep.26376
D
Danny Ka‐Ho Wong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
157
Papers
7.8K
Citations
53
h-index
115
i10-index
Danny Ka‐Ho Wong is an academic researcher from Chinese University of Hong Kong. The author has contributed to research in topics: Hepatitis B Virus Studies & Hepatitis C virus research & Liver Disease Diagnosis and Treatment. The author has an h-index of 53, co-authored 134 publications.
Papers by this author
worksDefining Normal Liver Stiffness Range in a Normal Healthy Chinese Population without Liver Disease
2013 · PLoS ONE · 53 citations
https://doi.org/10.1371/journal.pone.0085067
HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA
2020 · Scientific Reports · 31 citations
https://doi.org/10.1038/s41598-020-57637-z
Tumor suppressive role of mitochondrial sirtuin 4 in induction of G2/M cell cycle arrest and apoptosis in hepatitis B virus-related hepatocellular carcinoma
2021 · Cell Death Discovery · 26 citations
https://doi.org/10.1038/s41420-021-00470-8
Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma
2019 · BMC Cancer · 25 citations
https://doi.org/10.1186/s12885-019-6002-9
ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B
2024 · Journal of Hepatology · 25 citations
https://doi.org/10.1016/j.jhep.2024.03.022
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat